Sessa Capital logo

Sessa Capital

Crunchbase
Crunchbase

Deals on record

2

Common Fundraising Type

Seed

Tolerance Bio logo
Tolerance Bio

Biopharmaceutical

Sessa Capital logo
Pacific 8 Ventures logo
Columbus Venture Partners logo
Criteria Bio Ventures logo
Ben Franklin Technology Partners logo
BioAdvance logo

Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.

Seed
$20.2M
12/19/2024
Article
Tolerance Bio logo
Tolerance Bio

Biopharmaceutical

Columbus Venture Partners logo
Criteria Bio Ventures logo
Sessa Capital logo
BioAdvance logo
Ben Franklin Technology Partners logo

Tolerance Bio, Inc. is a biopharmaceutical company developing thymus-based therapies and iPSC-based cell treatments for immune-mediated diseases like cancer, autoimmunity, and transplant rejection.

Seed
$17.2M
10/15/2024
Article